Innovative approach to accelerate development of antimalarials
Prof. James McCarthy, member of the Australian Infectious Diseases Research Centre developed the 'Challenge Model' that is being used to accelerate the development of new medicines for malaria.
AID researchers are drawn from infectious disease experts from across QIMR and UQ who apply leading technologies to identify, understand and prevent infectious disease.
The core AID research themes are bacterial, viral, parasitic and fungal infectious diseases afflicting humans. This microbial pathogenesis research effort brings together basic science and clinical research.
AID links molecular microbiological and clinical expertise from the UQ Faculties of Science and Health Sciences, and UQCCR, QCMRI, IMB, AIBN and the Diamantina Institute.
Australian virus might be answer to effective Ebola vaccine
A study lead by Professor Alexander Khromykh from the Australian Infectious Diseases research centre at the University of Queensland has found an experimental Ebola vaccine made using an Australian virus called Kunjin that might help in the fight against the deadly Ebola virus.... read more
more news and events
AID Research Excellence Awards 2015
AID researchers have been awarded the AID Research Excellence Awards for excellent work done in their respective fields... read more
Nanopatch vaccine technology company attracts $25 million
Professor Mark Kendall, inventor of the Nanopath and founder of Vaccine technology company Vaxxas has attracted a $25 million research funding. The Nanopatch seeks to replace traditional needle and syringe methods with a small patch that delivers vaccines painlessly. "This investment is a key next step in advancing a series of clinical programs and develop a pipeline of new vaccine products for major diseases using Vaxxas' patented Nanopatch technology," Professor Kendall said.... read more